165 related articles for article (PubMed ID: 9768644)
1. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma.
Christin-Maitre S; Rongières-Bertrand C; Kottler ML; Lahlou N; Frydman R; Touraine P; Bouchard P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3450-3. PubMed ID: 9768644
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.
Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789
[TBL] [Abstract][Full Text] [Related]
3. Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone.
Ghayuri M; Liu JH
Obstet Gynecol; 2007 Feb; 109(2 Pt2):547-9. PubMed ID: 17267890
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman.
Välimäki MJ; Tiitinen A; Alfthan H; Paetau A; Poranen A; Sane T; Stenman UH
J Clin Endocrinol Metab; 1999 Nov; 84(11):4204-8. PubMed ID: 10566673
[TBL] [Abstract][Full Text] [Related]
5. Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman.
Sugita T; Seki K; Nagai Y; Saeki N; Yamaura A; Ohigashi S; Iwata A; Tatsuno I; Sekiya S
Gynecol Obstet Invest; 2005; 59(3):138-43. PubMed ID: 15637432
[TBL] [Abstract][Full Text] [Related]
6. Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion.
Kuhn JM; Lefebvre H; Duparc C; Pellerin A; Luton JP; Strauch G
J Clin Endocrinol Metab; 2002 May; 87(5):2367-75. PubMed ID: 11994389
[TBL] [Abstract][Full Text] [Related]
7. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.
Djerassi A; Coutifaris C; West VA; Asa SL; Kapoor SC; Pavlou SN; Snyder PJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):591-4. PubMed ID: 7852525
[TBL] [Abstract][Full Text] [Related]
8. Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation.
Pentz-Vidovíc I; Skorić T; Grubisić G; Korsíc M; Ivicevic-Bakulic T; Besenski N; Paladino J; Plavsic V; Zarković K
Eur J Endocrinol; 2000 Nov; 143(5):607-14. PubMed ID: 11078984
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature.
Kihara M; Sugita T; Nagai Y; Saeki N; Tatsuno I; Seki K
Gynecol Endocrinol; 2006 Feb; 22(2):110-3. PubMed ID: 16603438
[TBL] [Abstract][Full Text] [Related]
10. Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman.
Halupczok J; Bidzińska-Speichert B; Lenarcik-Kabza A; Zieliński G; Filus A; Maksymowicz M
Gynecol Endocrinol; 2014 Nov; 30(11):774-7. PubMed ID: 24971660
[TBL] [Abstract][Full Text] [Related]
11. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.
Roberts JE; Spandorfer S; Fasouliotis SJ; Lin K; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):208-10. PubMed ID: 15652911
[TBL] [Abstract][Full Text] [Related]
13. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
14. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
Murata Y; Ando H; Nagasaka T; Takahashi I; Saito K; Fukugaki H; Matsuzawa K; Mizutani S
J Clin Endocrinol Metab; 2003 May; 88(5):1988-93. PubMed ID: 12727942
[TBL] [Abstract][Full Text] [Related]
15. Follicle-stimulating hormone-secreting pituitary tumor with concomitant elevation of serum alpha-subunit levels.
Borges JL; Ridgway EC; Kovacs K; Rogol AD; Thorner MO
J Clin Endocrinol Metab; 1984 May; 58(5):937-41. PubMed ID: 6200493
[TBL] [Abstract][Full Text] [Related]
16. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
17. Gonadotroph cell adenomas of the pituitary.
Snyder PJ
Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
[TBL] [Abstract][Full Text] [Related]
18. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
[TBL] [Abstract][Full Text] [Related]
20. Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas.
Borgato S; Persani L; Romoli R; Cortelazzi D; Spada A; Beck-Peccoz P
J Endocrinol Invest; 1998 Jun; 21(6):372-9. PubMed ID: 9699129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
